Patent details

Basic Information

Publication number:

LUC00020

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP107212466

Legal Status:

Inactive

Application number:

LUC00020

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/16/1138

Marketing Authorization Type:

Marketing Authorization Date:

07/12/2016

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

Dates

Filing date:

22/05/2017

First Marketing Authorization date:

07/12/2016

Grant date:

03/08/2017

Activation date:

Publication date:

26/05/2017

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

07/12/2031

SPC Extension Expiration:

07/12/2031

Rejection date:

Withdrawal date:

Owner

From:

31/07/2025

 

 

Name:

ABBVIE MANUFACTURING MANAGEMENT UNLIMITED COMPANY

Address:

70 Sir John Rogerson’s Quay, Dublin 2, Ireland (IE)

Name:

GENENTECH, INC.

Address:

1 DNA WAY, SOUTH SAN FRANCISCO CA 94080-4990, United States (US)

Name:

THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH

Address:

1G Royal Parade, Parkville, Victoria 3050, Australia (AU)

History of Owners

From:

31/07/2025

To:

31/07/2025

Name:

ABBVIE IRELAND UNLIMITED COMPANY

Address:

70 Sir John Rogerson’s Quay, Dublin 2, Ireland (IE)

From:

14/06/2017

To:

31/07/2025

Name:

AbbVie Ireland Unlimited Company

Address:

c/o Conyers Corporate Services (Bermuda) Limited, Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda (BM)

From:

22/05/2017

To:

14/06/2017

Name:

AbbVie Bahamas Ltd.

Address:

Sassoon House, Shirley Street & Victoria Avenue, New Providence, Nassau, Bahamas (BS)

Agent

Name:

Office FREYLINGER S.A.

From:

22/05/2017

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Publication

Bulletin

1

Bulletin Heading:

SPC1

Bulletin edition number:

2017/03

Publication date:

21/07/2017

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:

CO

Bulletin edition number:

2017/03

Publication date:

21/07/2017

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

3

Bulletin Heading:

SPC2

Bulletin edition number:

2017/05

Publication date:

13/09/2017

Description:

Section D : Granted supplementary protection certificates – I2 publication

4

Bulletin Heading:

CO

Bulletin edition number:

2025/10

Publication date:

05/09/2025

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

5

Bulletin Heading:

CO

Bulletin edition number:

2025/10

Publication date:

05/09/2025

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

6

Bulletin Heading:

CO

Bulletin edition number:

2025/10

Publication date:

05/09/2025

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20170000203A

Date Registered:

14/06/2017

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

AbbVie Ireland Unlimited Company

Address:

c/o Conyers Corporate Services (Bermuda) Limited, Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda (BM)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of owner(s) name/address

Deed Number:

RC20250000269A

Date Registered:

31/07/2025

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

ABBVIE IRELAND UNLIMITED COMPANY

Address:

70 Sir John Rogerson’s Quay, Dublin 2, Ireland (IE)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20250000270A

Date Registered:

31/07/2025

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

ABBVIE MANUFACTURING MANAGEMENT UNLIMITED COMPANY

Address:

70 Sir John Rogerson’s Quay, Dublin 2, Ireland (IE)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20250000271A

Date Registered:

31/07/2025

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

1

Name:

GENENTECH, INC.

Address:

1 DNA WAY, SOUTH SAN FRANCISCO CA 94080-4990, United States (US)

2

Name:

ABBVIE MANUFACTURING MANAGEMENT UNLIMITED COMPANY

Address:

70 Sir John Rogerson’s Quay, Dublin 2, Ireland (IE)

3

Name:

THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH

Address:

1G Royal Parade, Parkville, Victoria 3050, Australia (AU)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

31/05/2030

Annual Fee Number:

21

Annual Fee Amount:

410 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
16/06/2017	Outgoing Correspondence	1
31/07/2025	Request For Change	2
01/08/2025	Outgoing Correspondence	1
31/07/2025	Request For Change	17
01/08/2025	Outgoing Correspondence	1
31/07/2025	Request For Change	14
01/08/2025	Outgoing Correspondence	1
14/06/2017	Request For Change	1
26/05/2017	Outgoing Correspondence	1
22/05/2017	General Document	2
26/05/2017	Publication	1
22/05/2017	General Document	4
22/05/2017	Application Form	4
22/05/2017	General Document	53